Last10K.com

Nanoviricides, Inc. (NNVC) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

Nanoviricides, Inc.

CIK: 1379006 Ticker: NNVC
Document And Entity Information - shares
9 Months Ended
Mar. 31, 2022
May 16, 2022
Document And Entity Information  
Document Type10-Q 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateMar. 31, 2022 
Entity Registrant NameNANOVIRICIDES, INC. 
Entity File Number001-36081 
Entity Incorporation, State or Country CodeNV 
Entity Tax Identification Number76-0674577 
Entity Address, Address Line One1 Controls Drive 
Entity Address, City or TownShelton 
Entity Address, State or ProvinceCT 
Entity Address, Postal Zip Code06484 
City Area Code203 
Local Phone Number937-6137 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Title of 12(b) SecurityCommon Stock 
Trading SymbolNNVC 
Security Exchange NameNYSE 
Entity Common Stock, Shares Outstanding 11,554,000
Amendment Flagfalse 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ3 
Entity Central Index Key0001379006 
Current Fiscal Year End Date--06-30 

View differences made from one quarter to another to evaluate Nanoviricides, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nanoviricides, Inc..

Continue

Assess how Nanoviricides, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nanoviricides, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
M & A
Other
Filter Subcategory:
All
Expense
Earnings
Product
Geography
Other
Inside Nanoviricides, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Balance Sheets
Balance Sheets (Parenthetical)
Statement Of Changes In Stockholders' Equity
Statements Of Cash Flows
Statements Of Operations
Commitments And Contingencies
Commitments And Contingencies (Details)
Equity Transactions
Equity Transactions (Tables)
Equity Transactions - Additional Information (Details)
Equity Transactions - Ceo (Details)
Equity Transactions - Fair Value Of Series A Preferred Stock (Details)
Equity Transactions - Warrants - Fair Value Assumptions (Details)
Liquidity
Liquidity (Details)
Loan Payable
Loan Payable (Details)
Organization And Nature Of Business
Organization And Nature Of Business (Details)
Property And Equipment
Property And Equipment (Tables)
Property And Equipment - Additional Information (Details)
Property And Equipment - Property And Equipment (Details)
Related Party Transactions
Related Party Transactions (Details)
Related Party Transactions (Tables)
Related Party Transactions - Additional Information (Details)
Related Party Transactions - Mortgage Note Payable - Related Party (Details)
Stock Warrants And Options
Stock Warrants And Options (Tables)
Stock Warrants And Options - Additional Information (Details)
Stock Warrants And Options - Stock Options (Details)
Stock Warrants And Options - Stock Warrants (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Additional Information (Details)
Summary Of Significant Accounting Policies - Warrants And Options (Details)
Trademark And Patents
Trademark And Patents (Tables)
Trademark And Patents - Additional Information (Details)
Trademark And Patents - Trademarks And Patents (Details)

Material Contracts, Statements, Certifications & more

Nanoviricides, Inc. provided additional information to their SEC Filing as exhibits

Ticker: NNVC
CIK: 1379006
Form Type: 10-Q Quarterly Report
Accession Number: 0001410578-22-001688
Submitted to the SEC: Mon May 16 2022 4:35:49 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Commercial Physical And Biological Research

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/nnvc/0001410578-22-001688.htm